Will Spectrum Pharmaceuticals, Inc. (SPPI) Stay at the Bottom of the Healthcare Sector?

Tuesday, November 16, 2021 11:31 AM | InvestorsObserver Analysts

Mentioned in this article

Will Spectrum Pharmaceuticals, Inc. (SPPI) Stay at the Bottom of the Healthcare Sector?

A rating of 49 puts Spectrum Pharmaceuticals, Inc. (SPPI) near the top of the Healthcare sector according to InvestorsObserver. Spectrum Pharmaceuticals, Inc.'s score of 49 means that it ranks higher than 49% of stocks in the sector. In addition, its overall score of 6 ranks it higher than 6% of all stocks.

SPPI has an Overall Score of 6. Find out what this means to you and get the rest of the rankings on SPPI!

See Full SPPI Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Spectrum Pharmaceuticals, Inc. Stock Today?

Spectrum Pharmaceuticals, Inc. (SPPI) stock is lower by -1% while the S&P 500 is higher by 0.49% as of 11:19 AM on Tuesday, Nov 16. SPPI is lower by -$0.02 from the previous closing price of $2.00 on volume of 294,764 shares. Over the past year the S&P 500 is higher by 29.74% while SPPI is lower by -52.97%. SPPI lost -$1.06 per share the over the last 12 months. Click Here to get the full Stock Report for Spectrum Pharmaceuticals, Inc. stock.